MDR inhibitors (Merrell)

N/A

Report date: 2026/03/30 17:02:26

Base Information

Drug NameMDR inhibitors (Merrell)
Drug Alias Nametriphenylazacycloalkane derivatives
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionAnticancer multidrug resistance inhibitors
TargetsUpdating
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesMerrell Pharmaceuticals Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesMerrell Pharmaceuticals Inc
Active IndicationsN/A
Inactive IndicationsNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A